45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
29,929
Insurances with rates
12
CPT / HCPCS codes
15,009
Source MRF
Most expensive procedures (gross)
00078084619
$1,689,825
TISAGENLECLEUCEL INTRAVENOUS SUSPENSION-ALL(RESTRICTED) [177718]
Gross
$3,379,649
73776000111
$1,495,560
LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION [199118]
Gross
$2,991,120
73776000112
$1,495,560
LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION [199118]
Gross
$2,991,120
59572051501
$1,447,377
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION [189558]
Gross
$2,894,754
59572051502
$1,447,377
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION [189558]
Gross
$2,894,754
59572051503
$1,447,377
IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION [189558]
Gross
$2,894,754
73153090108
$1,415,635
LISOCABTAGENE MARALEUCEL(CD8) 1.5X TO 70X 10EXP6 CELL/ML IV SUSP(1OF2) [189384]
Gross
$2,831,269
71287011901
$1,341,648
AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION (RESTRICTED) [177896]
Gross
$2,683,296
71287021901
$1,341,648
BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION [187126]
Gross
$2,683,296
00078095819
$1,326,957
TISAGENLECLEUCEL INTRAVENOUS SUSPENSION-DLBCL (RESTRICTED) [179656]
Gross
$2,653,914
71287021902
$1,231,296
BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION [187126]
Gross
$2,462,592
64406005801
$412,478
NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION [174701]
Gross
$824,956
71336100301
$346,596
VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE [193416]
Gross
$693,191
69866103005
$235,138
AUTOL CHONDROCYTE-COLLAG,PORC 500,000 CELL/CM2 (3 X 5 CM)IMPLANT SHEET [174710]
Gross
$470,276
25682002501
$233,311
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [188130]
Gross
$466,622
71336100101
$161,417
GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION [184636]
Gross
$322,834
75987015001
$161,417
INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION [186780]
Gross
$322,834
63004871001
$161,417
CORTICOTROPIN 80 UNIT/ML INJECTION GEL [9685]
Gross
$322,834
69488000301
$161,417
LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION [178865]
Gross
$322,834
50633021011
$159,591
GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION [116024]
Gross
$319,181
00310453530
$154,188
TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [195049]
Gross
$308,375
68152010303
$149,636
YTTRIUM 90 IBRITUMOMAB (ZEVALIN) INTRAVENOUS INJECTION [41815]
Gross
$299,271
69488001061
$147,022
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN [192514]
Gross
$294,044
27400123
$138,449
HC MOBILE POWER UNIT # 119923
Gross
$276,898
00003232822
$134,933
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [108956]
Gross
$269,867
72187040101
$124,611
TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION [182455]
Gross
$249,221
25682000101
$118,823
ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION [81696]
Gross
$237,646
71336100001
$113,799
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION [180618]
Gross
$227,598
58468020001
$113,017
ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION [165032]
Gross
$226,035
27800223
$106,005
HC CANNULA PROTEKDUO #117832
Gross
$212,010
79952011001
$104,742
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION [189946]
Gross
$209,485
72694095401
$98,986
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION [117842]
Gross
$197,973
66302020601
$97,113
TREPROSTINIL INSTITUTION START KIT 1.74 MG/2.9 ML SOLUTION FOR INHALATION (RESTRICTED) [99727]
Gross
$194,226
00187000714
$96,750
RIBAVIRIN 6 GRAM SOLUTION FOR INHALATION [11285]
Gross
$193,500
27800095
$96,568
HC Y-90 SIR SPHERES ISOTOPE
Gross
$193,135
66658051001
$96,207
EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION (RESTRICTED) [182082]
Gross
$192,413
72493010140
$93,121
MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT [186094]
Gross
$186,242
72493010303
$93,121
MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT [186094]
Gross
$186,242
25682002801
$91,014
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [188130]
Gross
$182,028
76128015575
$90,400
PORFIMER 75 MG INTRAVENOUS SOLUTION (RESTRICTED) [14472]
Gross
$180,800
00008010001
$87,478
INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN [177438]
Gross
$174,956
27800106
$83,389
HC DEVICE ASSIST CARDIOHELP HLS # 105701
Gross
$166,777
00074107001
$81,464
RISANKIZUMAB-RZAA 360 MG/2.4 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR [193426]
Gross
$162,927
00074106901
$81,464
RISANKIZUMAB-RZAA 360 MG/2.4 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR [193426]
Gross
$162,927
00074106601
$81,464
RISANKIZUMAB-RZAA 180 MG/1.2 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR [195523]
Gross
$162,927
00074106501
$81,464
RISANKIZUMAB-RZAA 180 MG/1.2 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR [195523]
Gross
$162,927
00074210001
$81,464
RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS PEN INJECTOR [190211]
Gross
$162,927
00074105001
$81,464
RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE [190212]
Gross
$162,927
80446040101
$78,528
TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION [192045]
Gross
$157,056
50242015001
$76,413
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION (RESTRICTED) [175495]
Gross
$152,826
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 00078084619 | TISAGENLECLEUCEL INTRAVENOUS SUSPENSION-ALL(RESTRICTED) [177718] | $3,379,649 | $1,689,825 | — | — | 0 |
| 73776000111 | LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION [199118] | $2,991,120 | $1,495,560 | — | — | 0 |
| 73776000112 | LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION [199118] | $2,991,120 | $1,495,560 | — | — | 0 |
| 59572051501 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION [189558] | $2,894,754 | $1,447,377 | — | — | 0 |
| 59572051502 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION [189558] | $2,894,754 | $1,447,377 | — | — | 0 |
| 59572051503 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 460 X 10EXP6 CELL IV SUSPENSION [189558] | $2,894,754 | $1,447,377 | — | — | 0 |
| 73153090108 | LISOCABTAGENE MARALEUCEL(CD8) 1.5X TO 70X 10EXP6 CELL/ML IV SUSP(1OF2) [189384] | $2,831,269 | $1,415,635 | — | — | 0 |
| 71287011901 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION (RESTRICTED) [177896] | $2,683,296 | $1,341,648 | — | — | 0 |
| 71287021901 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION [187126] | $2,683,296 | $1,341,648 | — | — | 0 |
| 00078095819 | TISAGENLECLEUCEL INTRAVENOUS SUSPENSION-DLBCL (RESTRICTED) [179656] | $2,653,914 | $1,326,957 | — | — | 0 |
| 71287021902 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION [187126] | $2,462,592 | $1,231,296 | — | — | 0 |
| 64406005801 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION [174701] | $824,956 | $412,478 | — | — | 0 |
| 71336100301 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE [193416] | $693,191 | $346,596 | — | — | 0 |
| 69866103005 | AUTOL CHONDROCYTE-COLLAG,PORC 500,000 CELL/CM2 (3 X 5 CM)IMPLANT SHEET [174710] | $470,276 | $235,138 | — | — | 0 |
| 25682002501 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [188130] | $466,622 | $233,311 | — | — | 0 |
| 71336100101 | GIVOSIRAN 189 MG/ML SUBCUTANEOUS SOLUTION [184636] | $322,834 | $161,417 | — | — | 0 |
| 75987015001 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION [186780] | $322,834 | $161,417 | — | — | 0 |
| 63004871001 | CORTICOTROPIN 80 UNIT/ML INJECTION GEL [9685] | $322,834 | $161,417 | — | — | 0 |
| 69488000301 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION [178865] | $322,834 | $161,417 | — | — | 0 |
| 50633021011 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION [116024] | $319,181 | $159,591 | — | — | 0 |
| 00310453530 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION [195049] | $308,375 | $154,188 | — | — | 0 |
| 68152010303 | YTTRIUM 90 IBRITUMOMAB (ZEVALIN) INTRAVENOUS INJECTION [41815] | $299,271 | $149,636 | — | — | 0 |
| 69488001061 | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN [192514] | $294,044 | $147,022 | — | — | 0 |
| 27400123 | HC MOBILE POWER UNIT # 119923 | $276,898 | $138,449 | — | — | 0 |
| 00003232822 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [108956] | $269,867 | $134,933 | — | — | 0 |
| 72187040101 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION [182455] | $249,221 | $124,611 | — | — | 0 |
| 25682000101 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION [81696] | $237,646 | $118,823 | — | — | 0 |
| 71336100001 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION [180618] | $227,598 | $113,799 | — | — | 0 |
| 58468020001 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION [165032] | $226,035 | $113,017 | — | — | 0 |
| 27800223 | HC CANNULA PROTEKDUO #117832 | $212,010 | $106,005 | — | — | 0 |
| 79952011001 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION [189946] | $209,485 | $104,742 | — | — | 0 |
| 72694095401 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION [117842] | $197,973 | $98,986 | — | — | 0 |
| 66302020601 | TREPROSTINIL INSTITUTION START KIT 1.74 MG/2.9 ML SOLUTION FOR INHALATION (RESTRICTED) [99727] | $194,226 | $97,113 | — | — | 0 |
| 00187000714 | RIBAVIRIN 6 GRAM SOLUTION FOR INHALATION [11285] | $193,500 | $96,750 | — | — | 0 |
| 27800095 | HC Y-90 SIR SPHERES ISOTOPE | $193,135 | $96,568 | — | — | 0 |
| 66658051001 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION (RESTRICTED) [182082] | $192,413 | $96,207 | — | — | 0 |
| 72493010140 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT [186094] | $186,242 | $93,121 | — | — | 0 |
| 72493010303 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT [186094] | $186,242 | $93,121 | — | — | 0 |
| 25682002801 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [188130] | $182,028 | $91,014 | — | — | 0 |
| 76128015575 | PORFIMER 75 MG INTRAVENOUS SOLUTION (RESTRICTED) [14472] | $180,800 | $90,400 | — | — | 0 |
| 00008010001 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN [177438] | $174,956 | $87,478 | — | — | 0 |
| 27800106 | HC DEVICE ASSIST CARDIOHELP HLS # 105701 | $166,777 | $83,389 | — | — | 0 |
| 00074107001 | RISANKIZUMAB-RZAA 360 MG/2.4 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR [193426] | $162,927 | $81,464 | — | — | 0 |
| 00074106901 | RISANKIZUMAB-RZAA 360 MG/2.4 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR [193426] | $162,927 | $81,464 | — | — | 0 |
| 00074106601 | RISANKIZUMAB-RZAA 180 MG/1.2 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR [195523] | $162,927 | $81,464 | — | — | 0 |
| 00074106501 | RISANKIZUMAB-RZAA 180 MG/1.2 ML (150 MG/ML) SUBCUT WEARABLE INJECTOR [195523] | $162,927 | $81,464 | — | — | 0 |
| 00074210001 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS PEN INJECTOR [190211] | $162,927 | $81,464 | — | — | 0 |
| 00074105001 | RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE [190212] | $162,927 | $81,464 | — | — | 0 |
| 80446040101 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION [192045] | $157,056 | $78,528 | — | — | 0 |
| 50242015001 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION (RESTRICTED) [175495] | $152,826 | $76,413 | — | — | 0 |
Showing top 50 of 29,929 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.